Onconetix, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Onconetix, Inc. (ONCO) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 4.42 million shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2025-11-13
- Onconetix, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2024-03-31 was 142.75K shares.
- Onconetix, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2023 was 142.75K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|---|---|
| 2025-09-30 | 4.42M shares 10-Q · filed 2025-11-13 | |||||
| 2024-06-30 | 1.68K shares 10-Q · filed 2025-08-14 | 5.71M shares 10-Q · filed 2024-08-29 | ||||
| 2024-03-31 | 142.75K shares 10-Q · filed 2025-06-12 | 5.71M shares 10-Q · filed 2024-05-20 | ||||
| 2023-12-31 | 142.75K shares 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |